Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Color Uniformity Measurement in Formulations – V 2.0

Posted on By

Analytical Method Development: SOP for Color Uniformity Measurement in Formulations – V 2.0

Standard Operating Procedure for Color Uniformity Testing of Pharmaceutical Formulations


Department Analytical Method Development
SOP No. SOP/AMD/184/2025
Supersedes SOP/AMD/184/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP establishes a validated procedure for measuring the color uniformity of pharmaceutical formulations using objective instrumental methods such as colorimetry or UV-visible spectrophotometry. It ensures compliance with visual appearance specifications and formulation

consistency.

2. Scope

This SOP applies to tablets, capsules, syrups, suspensions, emulsions, gels, and creams during analytical method development, in-process control, and batch release stages.

3. Responsibilities

  • Formulation Analyst: Collects and prepares representative samples for color evaluation.
  • Analytical Scientist: Develops and validates color measurement methods using calibrated equipment.
  • QA Officer: Reviews results against product specifications.
  • Head – AMD: Approves methods and ensures method integration with QMS.
See also  Analytical Method Development: SOP for Identification of Cream Base Components via FTIR - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the accuracy, objectivity, and traceability of all color uniformity measurements conducted for pharmaceutical products.

5. Procedure

5.1 Instrument Selection and Calibration

  1. Use one of the following:
    • Colorimeter (e.g., CIE L*a*b* system)
    • UV-Visible Spectrophotometer (λ max method for colored solutions)
  2. Calibrate instruments using standard white and black tiles for colorimeter or reference standards for spectrophotometer.
  3. Document calibration in Annexure-1: Instrument Calibration Log.

5.2 Sample Preparation

  1. For solid oral dosage forms:
    • Randomly select 10 units.
    • Place one unit at a time on the colorimeter sample plate and measure surface color at three distinct points.
  2. For liquids or semisolids:
    • Stir the sample gently to homogenize.
    • Transfer aliquot to a quartz or clear cuvette (1 cm pathlength).
  3. Ensure consistent lighting (D65) and observation angle (10°) for all measurements.

5.3 Measurement Parameters

  1. For colorimeter:
    • Record L* (lightness), a* (red/green), and b* (yellow/blue) values.
    • Calculate average ΔE* (total color difference) between test and reference samples.
  2. For UV-visible spectrophotometer:
    • Record absorbance at formulation-specific λ max (e.g., 420 nm for yellow colorants).
    • Compare absorbance readings across batches and sample locations.
See also  Analytical Method Development: Aseptic Technique SOP for AMD - V 2.0

5.4 Acceptance Criteria

  1. For colorimeter: ΔE* ≤ 2.0 indicates acceptable color uniformity.
  2. For spectrophotometer: RSD ≤ 2% between readings.
  3. Record findings in Annexure-2: Color Uniformity Report.

5.5 Method Validation

  1. Validate per ICH Q2(R2):
    • Precision: RSD ≤ 2% across replicate measurements.
    • Linearity: Standard color solutions across concentration range (R² ≥ 0.998).
    • Accuracy: Measured value recovery between 98–102% of true value.
    • Robustness: Reproducibility under varying light sources or observers.
  2. Summarize in Annexure-3: Validation Summary.

6. Abbreviations

  • RSD: Relative Standard Deviation
  • ΔE*: Total Color Difference
  • QMS: Quality Management System
  • SOP: Standard Operating Procedure
  • CIE: Commission Internationale de l’Éclairage

7. Documents

  1. Instrument Calibration Log – Annexure-1
  2. Color Uniformity Report – Annexure-2
  3. Validation Summary – Annexure-3
See also  Analytical Method Development: HPLC Assay Method Development - V 2.0

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • USP <1061> – Color and Appearance
  • Ph. Eur. 2.2.2 – Degree of coloration of liquids

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Instrument Calibration Log

Date Instrument ID Standard Tile/Ref. L* a* b* Analyst
18/05/2025 CLM-112 White Tile 94.3 -0.1 1.2 Rajesh Kumar

Annexure-2: Color Uniformity Report

Batch No. Formulation Type ΔE* Acceptance Criteria Status
BT-112 Tablet 1.7 ≤ 2.0 Complies

Annexure-3: Validation Summary

Parameter Result Criteria Status
Precision RSD = 1.6% ≤ 2% Pass
Linearity R² = 0.9987 ≥ 0.998 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded scope to include UV-Vis method and updated acceptance limits Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Process Validation of Gel Manufacturing – V 2.0
Next Post: Aerosol: SOP for Conducting Assay Testing of Active Ingredients in Aerosols – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version